| SARS-CoV-2–specific T cells are rapidly expanded for therapeutic use and target conserved regions of the membrane protein MD Keller, KM Harris, MA Jensen-Wachspress, VV Kankate, H Lang, ... Blood 136 (25), 2905-2917, 2020 | 122 | 2020 |
| NK cell adoptive immunotherapy of cancer: evaluating recognition strategies and overcoming limitations CE Sanchez, EP Dowlati, AE Geiger, K Chaudhry, MA Tovar, CM Bollard, ... Transplantation and cellular therapy 27 (1), 21-35, 2021 | 23 | 2021 |
| The generation and application of antigen-specific T cell therapies for cancer and viral-associated disease AB Hont, AB Powell, DK Sohai, IK Valdez, M Stanojevic, AE Geiger, ... Molecular Therapy, 2022 | 20 | 2022 |
| Co-transducing B7H3 CAR-NK cells with the DNR preserves their cytolytic function against GBM in the presence of exogenous TGF-β K Chaudhry, A Geiger, E Dowlati, H Lang, DK Sohai, EI Hwang, ... Molecular Therapy-Methods & Clinical Development 27, 415-430, 2022 | 14 | 2022 |
| Chimeric antigen receptor-engineered natural killer cells: a promising cancer immunotherapy K Chaudhry, E Dowlati, CM Bollard Expert Review of Clinical Immunology 17 (6), 643-659, 2021 | 6 | 2021 |
| Mimicry of embryonic circulation enhances the hoxa hemogenic niche and human blood development J Li, O Lao, FF Bruveris, L Wang, K Chaudry, Z Yang, N Farbehi, ES Ng, ... Cell Reports 40 (11), 111339, 2022 | 5 | 2022 |
| Modulation of anti-tumour activity of ex vivo expanded NK and GD2CAR-NK cells against neuroblastoma S Shen, K Ferrell, K Chaudhry, A Vu, R Nordon, T O'Brien Cytotherapy 21 (5), S20, 2019 | 3 | 2019 |
| Prolonging CART Cell Persistence Using Conditioning with 5-Azacytidine A Dolnikov, S Yang, S Shen, N Xu, K Chaudhry, R Nordon, T O'Brien Cytotherapy 18 (6), S98, 2016 | 2 | 2016 |
| Comparable transforming growth factor beta-mediated immune suppression in ex vivo-expanded natural killer cells from cord blood and peripheral blood: implications for adoptive … K Chaudhry, E Dowlati, MD Long, A Geiger, H Lang, EC Gomez, ... Cytotherapy, 2022 | 1 | 2022 |
| Immunotherapy: B7H3-CAR NK CELLS AND DNR CO-TRANSDUCED NK SHOWS MAINTAIN THEIR POTENCY AGAINST TGF-B MEDIATED IMMUNE SUPPRESSION K Chaudhry, A Geiger, E Dowlati, H Lang, E Yvon, M Holdoff, R Jones, ... Cytotherapy 24 (5), S38, 2022 | 1 | 2022 |
| Coronavirus-specific T-cells can be rapidly expanded from convalescent donors for potential clinical use MD Keller, KM Harris, S Conway, J Durkee-Shock, M Jensen-Wachspress, ... Transplantation and Cellular Therapy 27 (3), S70, 2021 | 1 | 2021 |
| Imaging the dynamics of receptor-modified T cell effector function against leukaemia and neuroblastoma targets K Chaudhry, S Shen, L Wang, D Bishop, K Micklethwaite, A Dolnikov, ... Cytotherapy 20 (5), S103, 2018 | 1 | 2018 |
| Multiscale imaging of endothelial cell guidance L Wang Graduate Schoolof Biomedical engineering, 2017 | 1 | 2017 |
| Immunotherapy: COMPARABLE TGF-β MEDIATED IMMUNE SUPPRESSION IN EX VIVO EXPANDED NK CELLS FROM CORD BLOOD AND PERIPHERAL BLOOD: IMPLICATIONS FOR ADOPTIVE IMMUNOTHERAPY K Chaudhry, E Dowlati, M Long, A Geiger, H Lang, C Sanchez, E Yvon, ... Cytotherapy 24 (5), S114, 2022 | | 2022 |
| The dynamics of anti-tumour responses generated by chimeric antigen receptor-modified immune effector cells K Chaudhry The University of New South Wales Sydney, Australia, 2018 | | 2018 |
| Droplet tweezers for single cell co-culture in a chemically isolated microenvironment A Hassanzadeh-Barforoushi, J Shemesh, K Chaudhry, R Nordon, ... | | |
